CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery [Phase 3]
Summary
Phase 3 clinical trial evaluating intraperitoneal ropivacaine for pain management in bariatric bypass surgery has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Bariatric Surgery Candidate | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15